In two seasons with the Eagles, Gardner-Johnson recorded 126 tackles, 20 pass breakups, and 12 interceptions. He brought a much-needed edge to a defense that needed intensity, and that energy catapulted Philadelphia to another championship.

There's been a lot of talk about why C.J. Gardner-Johnson was traded from the Eagles to the Texans. The safety joined "The Pivot" to discuss that and the story behind his Super Bowl parade shirt.

Johnson & Johnson ( JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion. Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse investors who want to collect a reliable payout.

A dozen House Republicans bucked Trump and Speaker Mike Johnson to prevent the legislation from advancing on the floor -- joining the entire Democratic caucus -- and, at least temporarily, freezing activity in the House. The final tally was 196-223.

Ben Johnson is entering his first season as head coach of the Chicago Bears. But where does he rank among the rest of the NFL coaches?

Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.

According to a July 10, 2025 SEC filing, the firm exited its entire position in Johnson & Johnson during Q2 2025, selling all 38,037 shares for $6,308,131 in reported transaction value. Andrew Hill Investment Advisors no longer holds JNJ shares as of June 30, 2025, based on 13F disclosures.

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research reiterated an ‘Outperform’ rating on the stock and a $175 price target. The bullish stance underscores the company’s strong performance year to date amid soaring regulatory concerns.